Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 21
1973 39
1974 55
1975 63
1976 166
1977 137
1978 141
1979 171
1980 139
1981 184
1982 179
1983 219
1984 230
1985 214
1986 234
1987 206
1988 187
1989 187
1990 158
1991 149
1992 148
1993 133
1994 134
1995 113
1996 131
1997 129
1998 114
1999 117
2000 132
2001 132
2002 150
2003 140
2004 160
2005 146
2006 161
2007 164
2008 198
2009 200
2010 189
2011 213
2012 218
2013 228
2014 254
2015 242
2016 260
2017 283
2018 273
2019 264
2020 295
2021 316
2022 291
2023 298
2024 166

Text availability

Article attribute

Article type

Publication date

Search Results

8,919 results

Results by year

Filters applied: . Clear all
Page 1
Tobramycin in ophthalmology.
Wilhelmus KR, Gilbert ML, Osato MS. Wilhelmus KR, et al. Surv Ophthalmol. 1987 Sep-Oct;32(2):111-22. doi: 10.1016/0039-6257(87)90103-2. Surv Ophthalmol. 1987. PMID: 3317953 Review.
Selman Waksman's laboratory at Rutgers University discovered the first aminoglycoside antibiotic, streptomycin, in 1943. Other aminoglycoside antibiotics, such as gentamicin and tobramycin, soon followed. Tobramycin is compatible with most intravenous fluids and tea …
Selman Waksman's laboratory at Rutgers University discovered the first aminoglycoside antibiotic, streptomycin, in 1943. Other aminoglycosid …
Tobramycin Nanoantibiotics and Their Advantages: A Minireview.
Rosalia M, Chiesa E, Tottoli EM, Dorati R, Genta I, Conti B, Pisani S. Rosalia M, et al. Int J Mol Sci. 2022 Nov 15;23(22):14080. doi: 10.3390/ijms232214080. Int J Mol Sci. 2022. PMID: 36430555 Free PMC article. Review.
This review paper is focused on what has been conducted in the last 20 years for the development of Tobramycin nanosized delivery systems (nanoantibiotics), with critical discussion and comparison. Tobramycin was selected as the antimicrobial drug because it is a wi …
This review paper is focused on what has been conducted in the last 20 years for the development of Tobramycin nanosized delivery sys …
[Tobramycin].
Yourassowsky E. Yourassowsky E. Acta Clin Belg. 1976;31(3):162-3. doi: 10.1080/17843286.1976.11717081. Acta Clin Belg. 1976. PMID: 948969 French. No abstract available.
Tobramycin for the treatment of bacterial pneumonia in children.
Bothra M, Lodha R, Kabra SK. Bothra M, et al. Expert Opin Pharmacother. 2012 Mar;13(4):565-71. doi: 10.1517/14656566.2012.656090. Epub 2012 Feb 1. Expert Opin Pharmacother. 2012. PMID: 22292783 Review.
AREAS COVERED: Information about the antimicrobial activity, pharmacological aspects (including pharmacokinetics and pharmacodynamics), clinical efficacy, safety and side effects of tobramycin have been covered in this review. EXPERT OPINION: A major advance for the use of …
AREAS COVERED: Information about the antimicrobial activity, pharmacological aspects (including pharmacokinetics and pharmacodynamics), clin …
Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1976;12(3):166-200. doi: 10.2165/00003495-197612030-00002. Drugs. 1976. PMID: 789045 Review.
Clinical experience with tobramycin is considerably less than with gentamicin. Whilst tobramycin appears to offer no clear advantages over gentamicin against sensitive organisms it is indicated in infection caused by strains of P. aeruginosa which are resistant to g …
Clinical experience with tobramycin is considerably less than with gentamicin. Whilst tobramycin appears to offer no clear adv …
Aspects of the pharmacology and toxicology of tobramycin in animals and humans.
Israel KS, Welles JS, Black HR. Israel KS, et al. J Infect Dis. 1976 Aug;134 Suppl:S97-103. doi: 10.1093/infdis/134.supplement_1.s97. J Infect Dis. 1976. PMID: 787452 Review.
The pharmacology and toxicology of tobramycin in animals and humans are reviewed. After intramuscular and intravenous administration, tobramycin diffuses throughout most body tissues and tissue fluids. ...Tobramycin crosses the placenta and is concentrated in …
The pharmacology and toxicology of tobramycin in animals and humans are reviewed. After intramuscular and intravenous administration, …
Tobramycin (Nebcin).
[No authors listed] [No authors listed] Drug Ther Bull. 1977 Feb 18;15(4):14-5. Drug Ther Bull. 1977. PMID: 837828 No abstract available.
Once-daily tobramycin.
Marino JT. Marino JT. Pediatr Pulmonol. 2002 May;33(5):407; author reply 407. doi: 10.1002/ppul.10034. Pediatr Pulmonol. 2002. PMID: 11948990 No abstract available.
Tobramycin Variants with Enhanced Ribosome-Targeting Activity.
Fosso MY, Zhu H, Green KD, Garneau-Tsodikova S, Fredrick K. Fosso MY, et al. Chembiochem. 2015 Jul 27;16(11):1565-70. doi: 10.1002/cbic.201500256. Epub 2015 Jun 17. Chembiochem. 2015. PMID: 26033429 Free PMC article.
With the increased evolution of aminoglycoside (AG)-resistant bacterial strains, the need to develop AGs with 1) enhanced antimicrobial activity, 2) the ability to evade resistance mechanisms, and 3) the capability of targeting the ribosome with higher efficiency is more and more …
With the increased evolution of aminoglycoside (AG)-resistant bacterial strains, the need to develop AGs with 1) enhanced antimicrobial acti …
8,919 results